Avalon GloboCare (ALBT) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free ALBT Stock Alerts $0.28 +0.01 (+3.77%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAvalon GloboCare Corp. (ALBT)finance.yahoo.com - April 25 at 7:05 AMAvalon GloboCare launches KetoAir breathalyzer in the USproactiveinvestors.com - April 23 at 8:49 AMAvalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conferenceglobenewswire.com - April 22 at 9:00 AMVaxcyte (NASDAQ:PCVX) & Avalon GloboCare (NASDAQ:ALBT) Head-To-Head Surveyamericanbankingnews.com - April 22 at 1:26 AMALBT Stock Earnings: Avalon Globocare Reported Results for Q4 2023msn.com - April 16 at 10:21 AMAvalon GloboCare extends exclusive distribution agreement for KetoAir breathalyzerproactiveinvestors.com - March 28 at 9:34 AMAvalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Unionglobenewswire.com - March 28 at 9:00 AMAvalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the USfinance.yahoo.com - December 18 at 9:55 AMAvalon Globocare Corp ALBTmorningstar.com - November 16 at 2:38 AMAvalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosisfinance.yahoo.com - October 18 at 1:56 PMApple Approves Use of Avalon GloboCare's KetoAir Mobile Applicationbenzinga.com - October 6 at 7:48 PMShareholders May Be A Bit More Conservative With Avalon GloboCare Corp.'s (NASDAQ:ALBT) CEO Compensation For Nowfinance.yahoo.com - October 6 at 9:47 AMAvalon GloboCare debuts KetoAir app on Apple App Storeproactiveinvestors.com - October 4 at 2:32 PMApple Approves Use of Avalon GloboCare’s KetoAir Mobile Applicationfinance.yahoo.com - October 4 at 9:32 AMNews Brief: Avalon GloboCare Corp.theglobeandmail.com - September 27 at 6:13 PMAvalon GloboCare shares spike on Laboratory Services MSO acquisitionsproactiveinvestors.com - September 13 at 7:14 PMAvalon GloboCare shares surge as recent momentum continuesproactiveinvestors.com - September 5 at 6:33 PMStocks in play: Avalon GloboCare Corp.ca.finance.yahoo.com - August 30 at 5:49 PMAvalon GloboCare investee LSM launches innovative lab test for tuberculosisproactiveinvestors.com - August 30 at 5:49 PMEXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosisfinance.yahoo.com - August 30 at 5:49 PMAvalon GloboCare announces Laboratory Services MSO’s expansion into Arizona; shares riseproactiveinvestors.com - August 21 at 3:53 PMAvalon GloboCare announces Laboratory Services MSO’s expansion into Arizonaproactiveinvestors.com - August 21 at 9:55 AMAvalon’s Laboratory Services MSO Announces Expansion into Arizonafinance.yahoo.com - August 21 at 9:55 AMAvalon GloboCare Second Quarter 2023 Earnings: US$0.25 loss per share (vs US$0.23 loss in 2Q 2022)finance.yahoo.com - August 16 at 6:26 AMAvalon GloboCare investee buys Houston-based lab testing facilityproactiveinvestors.com - July 24 at 1:34 PMAvalon GloboCare Shares Rise 12% After Lab Services Agreement With GeneXmarketwatch.com - July 19 at 2:56 PMAvalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 Statesfinance.yahoo.com - July 19 at 9:56 AMAvalon GloboCare says 2023 will be ‘pivotal year’ as it executes new commercial strategyproactiveinvestors.com - July 12 at 2:18 PMAvalon GloboCare Provides Update on New Commercial Strategyfinance.yahoo.com - July 10 at 12:32 PMIndustrial Logistics Properties Trust among financials gainers, Qudian in losersseekingalpha.com - June 14 at 1:16 PMAvalon Globocare Stock (NASDAQ:ALBT), Insider Trading Activitybenzinga.com - May 16 at 10:09 PMAvalon GloboCare highlights the 2022 results of its latest investment, Laboratory Services MSOproactiveinvestors.com - April 27 at 2:19 PMAvalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022finance.yahoo.com - April 27 at 9:18 AMAvalon GloboCare to launch its KetoAir breathalyzer device in North America at upcoming conferenceproactiveinvestors.com - April 17 at 9:40 AMAvalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conferencefinance.yahoo.com - April 17 at 9:40 AMAvalon GloboCare inks deal with Qi Diagnostics for distribution of KetoAir breathalyzerproactiveinvestors.com - April 11 at 3:13 PMAvalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Unionfinance.yahoo.com - April 11 at 10:12 AMALBT Avalon GloboCare Corp.seekingalpha.com - February 28 at 7:35 AMAvalon GloboCare acquires 40% interest in Laboratory Services MSO for $21Mmsn.com - February 13 at 1:23 PMAvalon GloboCare excited as it closes earnings accretive investment in testing firmproactiveinvestors.com - February 13 at 1:23 PMAvalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Companyfinance.yahoo.com - February 13 at 1:23 PMAvalon GloboCare says it has been issued with a US patent for multiple novel QTY-code modified cytokine and chemokine protein receptor moleculesproactiveinvestors.com - January 17 at 10:39 AMAvalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Moleculesfinance.yahoo.com - January 17 at 10:39 AMAvalon GloboCare appoints Lourdes Felix, CEO of a premier addiction treatment company, to its boardproactiveinvestors.com - January 11 at 1:47 PMAvalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directorsfinance.yahoo.com - January 11 at 1:47 PMmarketbeat.com - January 6 at 9:34 AMmarketbeat.com - January 5 at 12:24 PMmarketbeat.com - January 5 at 12:14 PMAvalon GloboCare Corp.: Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technologyfinanznachrichten.de - January 3 at 12:39 PMAvalon GloboCare reveals deployment of breakthrough fusion gene map technologyproactiveinvestors.com - January 3 at 12:39 PM Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy ALBT Media Mentions By Week ALBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALBT News Sentiment▼0.250.36▲Average Medical News Sentiment ALBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALBT Articles This Week▼50▲ALBT Articles Average Week Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kiromic BioPharma News Today Eloxx Pharmaceuticals News Today TRACON Pharmaceuticals News Today Gamida Cell News Today Windtree Therapeutics News Today Finch Therapeutics Group News Today Palisade Bio News Today Fresh Tracks Therapeutics News Today SQZ Biotechnologies News Today TC Biopharm News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALBT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
